Candel Therapeutics, Inc. CADL Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssets.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s other non-current assets?
- Candel Therapeutics, Inc. (CADL) reported other non-current assets of $108K in Q1 2026.
- How has Candel Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Candel Therapeutics, Inc.'s other non-current assets increased by 86.2% year-over-year, from $58K to $108K.
- What is the long-term trend for Candel Therapeutics, Inc.'s other non-current assets?
- Over 4 years (2020 to 2025), Candel Therapeutics, Inc.'s other non-current assets has grown at a -29.3% compound annual growth rate (CAGR), from $349K to $87K.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.